BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ambion, Inc. Opens Japanese Subsidiary


10/19/2005 5:12:59 PM

AUSTIN, Texas, March 9 /PRNewswire/ -- Ambion, Inc. announced today the formal opening of its Japanese subsidiary, Ambion KK, located in Tokyo, Japan. Ambion KK, which will be directly serving scientists in Japan, is the latest expansion of Ambion, Inc., a fifteen-year old company that develops, manufactures and markets research and diagnostic products for RNA-related applications to academic, industrial, clinical and government biotechnology scientists.

Dr. Matt Winkler, CEO of Ambion, Inc. said, "Our ability to offer services directly to our customers in Japan will allow us to develop closer relationships and offer additional services that will enhance their experience using our products and working with Ambion. This is a natural evolution in our growth."

Dr. Yosuke Sawada has been appointed President of Ambion KK. The Japan office has been established to focus on providing quality technical and customer service and fast direct shipment to dealers and customers.

Ambion, Inc., is a market leader in the field of RNA-based biotechnology research and molecular diagnostic products. Ambion maintains this leadership position by consistently developing innovative products for handling, preserving, isolating, detecting and measuring RNA. These products are used for research in areas such as molecular biology, cell biology, microbiology, drug discovery, genomics and molecular diagnostics.

Contacts: Bruce W. Leander President Ambion, Inc. (512) 651-0200

Ambion, Inc.

CONTACT: Bruce W. Leander, President of Ambion, +1-512-651-0200



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES